1	The	The	B-NP	DT	O	2	NMOD	0
2	modulation	modulation	I-NP	NN	O	0	ROOT	16	modulation
3	of	of	B-PP	IN	O	2	NMOD	0
4	platelet	platelet	B-NP	NN	B-cell_type	8	NMOD	0
5	and	and	O	CC	O	8	NMOD	0
6	endothelial	endothelial	B-NP	JJ	O	8	NMOD	0
7	cell	cell	I-NP	NN	O	8	NMOD	0
8	adhesion	adhesion	I-NP	NN	O	3	PMOD	15	adhesion
9	to	to	B-PP	TO	O	8	NMOD	0
10	vascular	vascular	B-NP	JJ	O	12	NMOD	0
11	graft	graft	I-NP	NN	O	12	NMOD	0
12	materials	material	I-NP	NNS	O	9	PMOD	0
13	by	by	B-PP	IN	O	2	NMOD	0
14	perlecan	perlecan	B-NP	NN	O	13	PMOD	0
15	.	.	O	.	O	2	P	0

1	Controlled	Control	B-NP	VBN	O	2	NMOD	16	Controlled
2	neo-endothelialisation	neo-endothelialisation	I-NP	NN	O	3	SUB	3	neo-endothelialisation
3	is	be	B-VP	VBZ	O	0	ROOT	0
4	critical	critical	B-ADJP	JJ	O	3	PRD	0
5	to	to	B-PP	TO	O	4	AMOD	0
6	the	the	B-NP	DT	O	7	NMOD	0
7	patency	patency	I-NP	NN	O	5	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	small	small	B-NP	JJ	O	12	NMOD	0
10	diameter	diameter	I-NP	NN	O	12	NMOD	0
11	vascular	vascular	I-NP	JJ	O	12	NMOD	0
12	grafts	graft	I-NP	NNS	O	8	PMOD	0
13	.	.	O	.	O	3	P	0

1	Endothelialisation	Endothelialisation	B-NP	NN	O	4	NMOD	3	Endothelialisation
2	and	and	I-NP	CC	O	4	NMOD	0
3	platelet	platelet	I-NP	NN	O	4	NMOD	0
4	adhesion	adhesion	I-NP	NN	O	14	NMOD	15	adhesion
5	to	to	B-PP	TO	O	4	NMOD	0
6	purified	purify	B-NP	VBN	O	9	NMOD	0
7	endothelial	endothelial	I-NP	JJ	O	9	NMOD	0
8	cell-derived	cell-derived	I-NP	JJ	O	9	NMOD	0
9	perlecan	perlecan	I-NP	NN	O	5	PMOD	0
10	,	,	O	,	O	14	P	0
11	the	the	B-NP	DT	O	14	NMOD	0
12	major	major	I-NP	JJ	O	14	NMOD	0
13	heparan	heparan	I-NP	NN	O	14	NMOD	0
14	sulfate	sulfate	I-NP	NN	O	18	NMOD	0
15	(	(	O	(	O	17	DEP	0
16	HS	HS	B-NP	NN	O	17	DEP	0
17	)	)	O	)	O	14	NMOD	0
18	proteoglycan	proteoglycan	B-NP	NN	O	23	SUB	0
19	in	in	B-PP	IN	O	18	NMOD	0
20	basement	basement	B-NP	NN	O	21	NMOD	0
21	membranes	membrane	I-NP	NNS	O	19	PMOD	0
22	,	,	O	,	O	18	P	0
23	were	be	B-VP	VBD	O	0	ROOT	0
24	investigated	investigate	I-VP	VBN	O	23	VC	0
25	using	use	B-VP	VBG	O	24	VMOD	0
26	in	in	B-ADVP	FW	O	27	AMOD	0
27	vivo	vivo	I-ADVP	FW	O	31	NMOD	0
28	and	and	O	CC	O	31	NMOD	0
29	in	in	B-NP	FW	O	30	AMOD	0
30	vitro	vitro	I-NP	FW	O	31	NMOD	0
31	assays	assay	I-NP	NNS	O	25	OBJ	0
32	.	.	O	.	O	23	P	0

1	Expanded	Expand	B-NP	VBN	O	2	NMOD	0
2	polytetrafluoroethylene	polytetrafluoroethylene	I-NP	NN	O	7	NMOD	0
3	(	(	O	(	O	5	DEP	0
4	ePTFE	ePTFE	B-NP	NN	O	5	DEP	0
5	)	)	O	)	O	2	NMOD	0
6	vascular	vascular	B-NP	JJ	O	7	NMOD	0
7	grafts	graft	I-NP	NNS	O	8	SUB	0
8	were	be	B-VP	VBD	O	0	ROOT	0
9	coated	coat	I-VP	VBN	O	8	VC	19	coated
10	with	with	B-PP	IN	O	9	VMOD	0
11	perlecan	perlecan	B-NP	NN	O	10	PMOD	0
12	and	and	O	CC	O	9	VMOD	0
13	tested	test	B-VP	VBN	O	9	VMOD	0
14	in	in	B-PP	IN	O	13	VMOD	0
15	an	an	B-NP	DT	O	19	NMOD	0
16	ovine	ovine	I-NP	JJ	O	19	NMOD	0
17	carotid	carotid	I-NP	NN	O	19	NMOD	0
18	interposition	interposition	I-NP	NN	O	19	NMOD	0
19	model	model	I-NP	NN	O	14	PMOD	0
20	for	for	B-PP	IN	O	19	NMOD	0
21	a	a	B-NP	DT	O	22	NMOD	0
22	period	period	I-NP	NN	O	20	PMOD	0
23	of	of	B-PP	IN	O	22	NMOD	0
24	6	6	B-NP	CD	O	25	NMOD	0
25	weeks	week	I-NP	NNS	O	23	PMOD	0
26	and	and	O	CC	O	9	VMOD	0
27	assessed	assess	B-VP	VBN	O	9	VMOD	0
28	using	use	B-VP	VBG	O	27	VMOD	0
29	light	light	B-NP	NN	O	32	NMOD	0
30	and	and	I-NP	CC	O	32	NMOD	0
31	scanning	scanning	I-NP	NN	O	32	NMOD	0
32	microscopy	microscopy	I-NP	NN	O	28	OBJ	0
33	.	.	O	.	O	8	P	0

1	Enhanced	Enhance	B-NP	VBN	O	4	NMOD	17	Enhanced
2	endothelial	endothelial	I-NP	JJ	O	4	NMOD	0
3	cell	cell	I-NP	NN	O	4	NMOD	0
4	growth	growth	I-NP	NN	O	8	NMOD	1	growth
5	and	and	O	CC	O	8	NMOD	0
6	reduced	reduce	B-VP	VBD	O	8	NMOD	18	reduced
7	platelet	platelet	B-NP	NN	O	8	NMOD	0
8	adhesion	adhesion	I-NP	NN	O	9	SUB	15	adhesion
9	were	be	B-VP	VBD	O	0	ROOT	0
10	observed	observe	I-VP	VBN	O	9	VC	0
11	on	on	B-PP	IN	O	10	VMOD	0
12	the	the	B-NP	DT	O	13	NMOD	0
13	perlecan	perlecan	I-NP	NN	O	11	PMOD	0
14	coated	coat	B-VP	VBD	O	9	VMOD	19	coated
15	grafts	graft	B-NP	NNS	O	14	OBJ	0
16	when	when	B-ADVP	WRB	O	14	VMOD	0
17	compared	compare	B-VP	VBN	O	16	SBAR	0
18	to	to	B-PP	TO	O	17	VMOD	0
19	uncoated	uncoated	B-NP	JJ	O	20	NMOD	19	uncoated
20	controls	control	I-NP	NNS	O	18	PMOD	0
21	implanted	implant	B-VP	VBN	O	20	NMOD	19	implanted
22	in	in	B-PP	IN	O	21	VMOD	0
23	the	the	B-NP	DT	O	25	NMOD	0
24	same	same	I-NP	JJ	O	25	NMOD	0
25	sheep	sheep	I-NP	NN	O	22	PMOD	0
26	(	(	O	(	O	28	DEP	0
27	n=5	n=5	B-NP	NN	O	28	DEP	0
28	)	)	O	)	O	25	NMOD	0
29	.	.	O	.	O	9	P	0

1	Perlecan	Perlecan	B-NP	NN	O	2	SUB	0
2	was	be	B-VP	VBD	O	0	ROOT	0
3	also	also	I-VP	RB	O	2	VMOD	0
4	found	find	I-VP	VBN	O	2	VC	0
5	to	to	I-VP	TO	O	6	VMOD	0
6	stimulate	stimulate	I-VP	VB	O	4	VMOD	17	stimulate
7	endothelial	endothelial	B-NP	JJ	B-cell_type	9	NMOD	0
8	cell	cell	I-NP	NN	I-cell_type	9	NMOD	0
9	proliferation	proliferation	I-NP	NN	O	6	OBJ	1	proliferation
10	in	in	B-ADVP	FW	O	6	VMOD	0
11	vitro	vitro	I-ADVP	FW	O	10	AMOD	0
12	over	over	B-PP	IN	O	6	VMOD	0
13	a	a	B-NP	DT	O	14	NMOD	0
14	period	period	I-NP	NN	O	12	PMOD	0
15	of	of	B-PP	IN	O	14	NMOD	0
16	6	6	B-NP	CD	O	17	NMOD	0
17	days	day	I-NP	NNS	O	15	PMOD	0
18	in	in	B-PP	IN	O	14	NMOD	0
19	the	the	B-NP	DT	O	20	NMOD	0
20	presence	presence	I-NP	NN	O	18	PMOD	14	presence
21	of	of	B-PP	IN	O	20	NMOD	0
22	plasma	plasma	B-NP	NN	B-protein	23	NMOD	0
23	proteins	protein	I-NP	NNS	I-protein	27	NMOD	0
24	and	and	O	CC	O	27	NMOD	0
25	fibroblastic	fibroblastic	B-NP	JJ	B-protein	27	NMOD	0
26	growth	growth	I-NP	NN	I-protein	27	NMOD	0
27	factor	factor	I-NP	NN	I-protein	21	PMOD	0
28	2	2	I-NP	CD	I-protein	27	NMOD	0
29	(	(	O	(	O	31	DEP	0
30	FGF-2	FGF-2	B-NP	NN	B-protein	31	DEP	0
31	)	)	O	)	O	27	NMOD	0
32	,	,	O	,	O	6	P	0
33	however	however	B-ADVP	RB	O	42	VMOD	0
34	in	in	B-PP	IN	O	42	SUB	0
35	the	the	B-NP	DT	O	36	NMOD	0
36	absence	absence	I-NP	NN	O	34	PMOD	14	absence
37	of	of	B-PP	IN	O	36	NMOD	0
38	FGF-2	FGF-2	B-NP	NN	B-protein	41	NMOD	0
39	endothelial	endothelial	I-NP	JJ	O	41	NMOD	0
40	cell	cell	I-NP	NN	O	41	NMOD	0
41	growth	growth	I-NP	NN	O	37	PMOD	1	growth
42	could	could	B-VP	MD	O	6	VMOD	0
43	not	not	I-VP	RB	O	42	VMOD	0
44	be	be	I-VP	VB	O	42	VC	0
45	maintained	maintain	I-VP	VBN	O	44	VC	0
46	during	during	B-PP	IN	O	45	VMOD	0
47	this	this	B-NP	DT	O	48	NMOD	0
48	period	period	I-NP	NN	O	46	PMOD	0
49	.	.	O	.	O	2	P	0

1	Perlecan	Perlecan	B-NP	NN	O	2	SUB	0
2	was	be	B-VP	VBD	O	0	ROOT	0
3	found	find	I-VP	VBN	O	2	VC	0
4	to	to	I-VP	TO	O	5	VMOD	0
5	be	be	I-VP	VB	O	3	VMOD	0
6	anti-adhesive	anti-adhesive	B-ADJP	JJ	O	5	PRD	15	anti-adhesive
7	for	for	B-PP	IN	O	6	AMOD	0
8	platelets	platelet	B-NP	NNS	B-cell_type	7	PMOD	0
9	,	,	O	,	O	2	P	0
10	however	however	B-ADVP	RB	O	11	PMOD	0
11	after	after	B-PP	IN	O	2	VMOD	0
12	removal	removal	B-NP	NN	O	11	PMOD	0
13	of	of	B-PP	IN	O	12	NMOD	0
14	the	the	B-NP	DT	O	16	NMOD	0
15	HS	HS	I-NP	NN	B-protein	16	NMOD	0
16	chains	chain	I-NP	NNS	I-protein	13	PMOD	0
17	attached	attach	B-VP	VBN	O	16	NMOD	0
18	to	to	B-PP	TO	O	17	VMOD	0
19	perlecan	perlecan	B-NP	NN	O	22	NMOD	0
20	,	,	I-NP	,	O	22	P	0
21	platelet	platelet	I-NP	NN	O	22	NMOD	0
22	adhesion	adhesion	I-NP	NN	O	24	NMOD	15	adhesion
23	and	and	I-NP	CC	O	24	NMOD	0
24	aggregation	aggregation	I-NP	NN	O	18	PMOD	15	aggregation
25	were	be	B-VP	VBD	O	2	VMOD	0
26	supported	support	I-VP	VBN	O	25	VC	0
27	.	.	O	.	O	2	P	0

1	These	These	B-NP	DT	O	2	NMOD	0
2	results	result	I-NP	NNS	O	3	SUB	0
3	suggest	suggest	B-VP	VBP	O	0	ROOT	0
4	a	a	B-NP	DT	O	5	NMOD	0
5	role	role	I-NP	NN	O	3	OBJ	0
6	for	for	B-PP	IN	O	5	NMOD	0
7	HS	HS	B-NP	NN	B-protein	8	NMOD	0
8	chains	chain	I-NP	NNS	I-protein	6	PMOD	0
9	of	of	B-PP	IN	O	8	NMOD	0
10	perlecan	perlecan	B-NP	NN	O	9	PMOD	0
11	in	in	B-PP	IN	O	5	NMOD	0
12	improving	improve	B-VP	VBG	O	11	PMOD	0
13	graft	graft	B-NP	NN	O	14	NMOD	0
14	patency	patency	I-NP	NN	O	12	OBJ	0
15	by	by	B-PP	IN	O	12	VMOD	0
16	selectively	selectively	B-ADVP	RB	O	17	VMOD	0
17	promoting	promote	B-VP	VBG	O	15	PMOD	17	promoting
18	endothelial	endothelial	B-NP	JJ	O	20	NMOD	0
19	cell	cell	I-NP	NN	O	20	NMOD	0
20	proliferation	proliferation	I-NP	NN	O	17	OBJ	1	proliferation
21	while	while	B-SBAR	IN	O	17	VMOD	0
22	modulating	modulate	B-VP	VBG	O	21	SBAR	16	modulating
23	platelet	platelet	B-NP	NN	O	24	NMOD	0
24	adhesion	adhesion	I-NP	NN	O	22	OBJ	15	adhesion
25	.	.	O	.	O	3	P	0

